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NC-ND license (http://creativecommoPulmonary hypoplasia is a substantial cause of death in newborn infants, and oligohydramnios
is one of the most commonly associated abnormalities. Lung growth is influenced by physical
factors such as the intrauterine space, lung liquid volume and pressure, and fetal breathing
movements. During lung development, the main physical force experienced by the lungs is
stretching induced by breathing movements and the lung fluid in the airspaces. Oligohydram-
nios reduces the intrathoracic cavity size, thus disrupting fetal lung growth and leading to pul-
monary hypoplasia. The exact mechanism by which oligohydramnios alters the respiratory
system structure and the effect of oligohydramnios on long-term respiratory outcomes remain
unknown. In this review, we summarize the effects of oligohydramnios on lung development,
discuss the mechanisms of oligohydramnios-induced pulmonary hypoplasia identified in various
animal studies, and describe the long-term respiratory outcomes in childhood of
oligohydramnios-exposed fetuses reported by a population-based study.
Copyright ª 2016, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).of Pediatrics, Taipei Medical University Hospital, 252, Wu-Hsing Street, Taipei 110, Taiwan.
tw (C.-M. Chen).
u C-S, et al., Pulmonary Hypoplasia Induced by Oligohydramnios: Findings from Animal Models and a
nd Neonatology (2016), http://dx.doi.org/10.1016/j.pedneo.2016.04.001
016.04.001
ediatric Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-
ns.org/licenses/by-nc-nd/4.0/).
2 C.-S. Wu et al
+ MODEL1. Introduction
Pulmonary hypoplasia is a developmental anomaly charac-
terized by underdevelopment of the lung tissue and is a
common finding (up to 22%) in neonatal autopsies.1 Pul-
monary hypoplasia secondary to congenital diaphragmatic
hernia, oligohydramnios, and renal agenesis is a major
cause of neonatal morbidity and mortality. Amniotic fluid is
produced from maternal plasma and secreted from the
fetal membranes. Fetal urine contributes to the amniotic
fluid when the fetal kidneys start to function. Brace et al2
found that fetal swallowing of amniotic fluid regulates the
amniotic fluid volume in late-gestation sheep. Oligohy-
dramnios may restrict fetal lung growth and can result in
pulmonary hypoplasia in experimental animal models and
human fetuses with prolonged rupture of the fetal mem-
branes.3,4 Neonates exposed to oligohydramnios caused by
the premature rupture of the membranes have an increased
risk of acute respiratory morbidity such as pulmonary hy-
pertension and air leaks.5 Currently, management of the
condition is primarily supportive, and specific treatments
designed for accelerating lung development are lacking.6
The exact mechanism by which oligohydramnios induces
lung hypoplasia and alters the respiratory system structure
remains unknown. An understanding of the molecular and
pathophysiological processes controlling fetal lung growth
and development during oligohydramnios holds potential
for developing novel therapies for preventing and treating
oligohydramnios-induced pulmonary hypoplasia.2. Normal lung development
Studies have supported the use of rodents for studying
oligohydramnios because their alveolarization phase re-
sembles that of humans (Figure 1).7 Lung development
begins as a ventral outpouching of endodermal cells from
the anterior foregut into the surrounding mesenchyme at
9.5 days postconception (E9.5) in mice. This ventral diver-
ticulum grows caudally to form the primitive trachea and
subsequently divides to form two lung buds. During the
pseudoglandular phase (E9.5eE16 in mice; 6e16 weeks
gestation in humans), the lung buds undergo repeated
dichotomous branching to form the bronchioles, respiratory
bronchioles, and alveolar ducts. Paracrine factors producedFigure 1 Timeline for lung development in the mouse, rat,
and human respiratory systems.
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for the dichotomous branching of the bronchiolar epithe-
lium during this phase of development. Between 16 days
and 17 days postconception in mice (canalicular phase in
mice; 16e26 weeks gestation in humans), the rapid growth
rate of lung tissue declines and dichotomous branching is
completed. This phase is characterized by the onset of
capillary growth within the developing lung and by the
appearance of type II cells containing lamellar bodies, the
cellular organelles that comprise lung surfactants. During
the saccular phase of lung development (E17ebirth in mice;
26e36 weeks gestation in humans), the capillaries continue
to grow, and the distal lung is remodeled to resemble the
adult lung parenchyma. This remodeling includes the sus-
tained growth of capillary networks, cellular differentia-
tion, thinning of mesenchyme-derived stroma, and
expansion of the developing alveoli.8
Physical forces are crucial for regulating fetal lung
growth and maturation.9 Distended pressure formed by lung
fluid within the airways is the primary physical force stim-
ulating the lungs during normal lung development.10
Furthermore, the fetus exhibits episodic fetal breathing
movements (FBMs), which are accepted as part of normal
human lung development.11,12 According to changes in
thoracic shape, Kitterman12 speculated that FBMs result in
repetitive changes in the distal lung surface area by w5%.
Functional maturation of pulmonary alveolar epithelial
cells was promoted by lung stretch at various degrees in
experiments involving fetal rat lungs and type II epithelial
cells.13 Drainage of lung fluid in fetal sheep or elimination
of FBMs by cervical cord transection in the rabbit fetus
leads to lung hypoplasia.14,15 Hence, distended pressure
generated by lung fluid and cyclic stretch of the lung are
the two major determinants of normal fetal lung
development.3. Effects of oligohydramnios on growth factor
expression
Lung growth and development require extrinsic factors and
mechanical forces.12,13,16 Experimental tracheal ligation in
fetal lambs indicated that the fetal lung liquid volume is
vital for lung development.17 Additionally, several in vitro
and in vivo studies have suggested that FBMs regulate lung
growth by activating growth factor expression.18
Platelet-derived growth factor (PDGF) is a powerful
stimulator of fibroblast chemotaxis and proliferation and is
crucial for the alveolarization of normally developing
lungs.19e21 PDGFs are homodimers or heterodimers
comprising two distinct polypeptide chains (A and B), which
can be dimerized via sulfhydryl bridges to form three
bioactive isoforms (AA, BB, and AB).22 Studies have
demonstrated that mechanical strain on the lungs increases
PDGF production and activates PDGF receptors in vascular
smooth muscle cells.23 Souza et al24,25 used antisense oli-
gonucleotides in an embryonic rat lung explant culture and
reported that PDGFs play critical roles in early lung growth
and branching morphogenesis.
PDGF-A and its receptor are essential in lung elasto-
genesis and alveolarization.26 Haider et al27 found that the
absence of elastic tissue in hypoplastic human fetal lungsia Induced by Oligohydramnios: Findings from Animal Models and a
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tion in the developing lung, elastin is deposited in the
mesenchyme surrounding the developing distal airways.
During alveolarization, elastin is deposited at the apex of
the secondary septal crests.28 Oligohydramnios induced at
the pseudoglandular stage of lung development reduced
elastin deposition, alveolarization, and the expression of
PDGF and its receptors in a rat model.29
Connective tissue growth factor (CTGF) is involved in
fibroblast proliferation, cellular adhesion, and extracellular
matrix synthesis.30 Moreover, CTGF contributes to collagen
deposition during downstream expression of transforming
growth factor (TGF)-b1,31 which stimulates collagen syn-
thesis in human embryonic lung fibroblast cultures.32 A
previous study showed that mechanical-stretching-induced
type I collagen mRNA expression is blocked by anti-TGF-b
neutralizing antibodies in cultured rat mesangial cells.33
Oligohydramnios induced on Day 19 and Day 21 of gesta-
tion was shown to reduce TGF-b1 expression, lung collagen
levels (type I collagen), and level of tissue inhibitor of
metalloproteinase (TIMP)-1 proteins, but nevertheless, it
increased matrix metalloproteinase (MMP)-1 concentra-
tions. In addition, there was no difference in CTGF
expression between control and oligohydramnios-exposed
rats.34 These data indicated that no autocrine loop of
CTGF is involved in the signaling cascade induced by oli-
gohydramnios and that downregulation of collagen syn-
thesis might be related to the pathogenesis of
oligohydramnios-induced respiratory morbidity.
Vascular endothelial growth factor (VEGF) is a potent
endothelial cell mitogen that regulates endothelial cell
differentiation and angiogenesis.35 Angiogenesis is physio-
logically crucial for alveolarization during normal lung
development.36 Oligohydramnios induced at the pseudo-
glandular stage of lung development reduced angiogenesis
and did not significantly reduce VEGF expression in a rat
model.37 These studies suggest that the development of the
pulmonary vasculature is complex and that other angio-
genic factors are involved in regulating fetal lung
angiogenesis.
Alveolar development in mice treated with an angio-
genesis inhibitor could be maintained after vitamin A sup-
plementation.38,39 Vitamin A treatment improved lung
development in ventilated preterm lambs by increasing the
expression of VEGF and its receptor.40 An in vitro study
suggested that exogenous retinoic acid may enhance lung
alveolarization by activating fibroblast proliferation via
PDGF.41 Nevertheless, VEGF expression and fetal lung
development were not enhanced after maternal retinoic
acid treatment in oligohydramnios-exposed fetal rat
lungs.37,42 Therefore, additional studies are warranted to
clarify the reasons for discordance among these studies,
such as a stage-specific requirement for retinoic acid during
lung development.4. Oligohydramnios reduces collagen and
elastin expression
Collagen fibrils, which are important for maintaining the
normal lung structure, are distributed widely in the alve-
olar interstitium, the bronchial lamina propria, thePlease cite this article in press as: Wu C-S, et al., Pulmonary Hypoplasi
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tree. Elastin is also a vital structural component of the lung,
enabling the expansion and recoil of the pulmonary pa-
renchyma.43 Elastin is deposited at the apex of the sec-
ondary septal crests during alveolarization, and on the
mesenchyme surrounding the developing distal airways
before alveolarization in the developing lungs.28 Elastin
haploinsufficiency adversely affects pulmonary angiogen-
esis, resulting in lung growth arrest and impaired respira-
tory function.44
During the pseudoglandular stage of lung development,
lung collagen I expression and the collagen level were
shown to decrease in fetal rats exposed to maternal oli-
gohydramnios.34 Additionally, the absence of elastic tissue
in hypoplastic human fetal lungs is associated with
maternal oligohydramnios.27,45 A balance between collagen
synthesis and degradation is achieved through the de novo
synthesis of collagen, inhibition of MMP activity by tissue
TIMPs, and proteolytic degradation by MMPs.46,47 Activation
of metalloproteinase can be induced by an imbalance in
MMP and TIMP levels. Collagen degradation in interstitial
spaces is stimulated by a higher level of MMP than TIMP,
which is induced by maternal oligohydramnios, in fetal rat
lungs. Altered extracellular matrix content caused by
maternal oligohydramnios, which is found in fetal rat lung
models, might correspond to the altered respiratory func-
tion of the offspring.5. Effect of oligohydramnios on respiratory
outcomes in children
Lindner et al5 observed that neonates exposed to oligo-
hydramnios experienced short-term respiratory morbidity
and tended to experience more air leaks than did healthy
neonates. A small caseecontrol study found that infants
exposed to prolonged oligohydramnios born following the
preterm premature rupture of the membranes prior to 25
weeks gestation were at a high risk of prolonged initial
hospitalization and major respiratory morbidity in their
first 2 years of life.48 However, the long-term effects of
oligohydramnios on the respiratory system are unknown.
In a retrospective cohort study, Chien et al49 observed
that oligohydramnios-exposed children had an 8% higher
incidence rate of respiratory hospitalization (ICD-9-CM:
493, 494, 496, 512, 518, 786.00, 786.05, 786.07, 786.09,
786.1e786.4, 799.02, or 799.1, 466, 480e487, 490, 491,
510, or 513, 786) and an 80% higher incidence rate for
respiratory failure (ICD-9-CM: 96.70, 96.71, or 96.72)
compared with children without oligohydramnios expo-
sure. This risk remained following adjustment for neonatal
characteristics, parental demographics, insurance eligi-
bility group, urbanization level of insurance registration
area, level of prenatal care, and maternal risk factors.
The findings of this study provide useful clinical implica-
tions, especially for risk and prognosis evaluation, man-
agement adjustment, and education on respiratory
outcomes for parents of maternal oligohydramnios-
exposed children.
Pulmonary hypoplasia, which can be induced by
maternal oligohydramnios in human fetuses, is associated
with decreased lung function in infants. However, thea Induced by Oligohydramnios: Findings from Animal Models and a
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Figure 2 Proposed mechanism of prenatal exposure to oli-
gohydramnios leading to susceptibility to respiratory disease in
offspring. PDGF Z platelet-derived growth factor;
TGF Z transforming growth factor; VEGF Z vascular endo-
thelial growth factor.
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respiratory system and its effects on long-term respiratory
outcomes remain unclear. According to a series of studies
with an established animal model29,34,37,42 and a
population-based study,49 a schematic diagram illustrating
prenatal exposure to oligohydramnios and the implications
for subsequent respiratory disease is provided in Figure 2.6. Conclusions
Rats subjected to oligohydramnios on Day 16 of gestation
exhibited lung hypoplasia and a marked decrease in
extracellular matrix expression. Similarly, decreases in
PDGF and TGF-b1 expression were observed on Day 19 and
Day 21 of gestation. Concomitant treatment with maternal
retinoic acid increased PDGF expression but did not
enhance fetal lung development. In a matched retrospec-
tive cohort study, oligohydramnios-exposed children had a
higher incidence rate of respiratory illnesses and were
associated with increased healthcare use. Additional basic
translational and clinical studies are warranted in the fields
of oligohydramnios, pulmonary dysplasia, and extreme
prematurity because the incomplete development of the
lungs was shown in our investigations to share a common set
of features. For example, maternal or postnatal vitamin A
administration during the canalicular stage of lung devel-
opment in oligohydramnios-exposed offspring. Developing
effective strategies for preventing or treating pulmonary
dysplasia induced by maternal oligohydramnios can
improve prognosis and reduce the rate of respiratory
morbidity in these children.Conflicts of interest
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